CrystalGenomics Rises 13.0% Amid COVID-19 (Camostat) Theme Uptrend

On the 24th, the COVID-19 (Camostat) theme rose 4.06% compared to the previous day, showing strength, while CrystalGenomics, a related stock attracting attention, surged 13.0% compared to the previous day. CrystalGenomics is known as a company specializing in new drug development, including arthritis treatments and novel antibiotics.

[Graph] Major stock price changes in the COVID-19 (Camostat) theme

According to provisional data compiled at 11:46, foreign investors are net selling -22,300 shares of CrystalGenomics.

[Table] Net trading volume by foreigners and institutions (unit: 10,000 shares)

According to the analysis by Thinkpool Robo Algorithm RASSI, CrystalGenomics’ quant financial score is 18.59 points, ranking 3rd in the quant financial ranking within the COVID-19 (Camostat) related theme. This can be interpreted as CrystalGenomics having relatively low investment attractiveness from a financial perspective. On the other hand, Ilseong Pharmaceutical ranked 1st in the quant financial ranking with higher stability and profitability scores compared to the average of other stocks.

[Table] Top stocks by financial score within the theme

※ The quant financial score is the result of the Robo Algorithm analyzing each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist Thinkpool.

This content was produced with the assistance of AI translation services.